Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. Announces Board Election Results at Annual Meeting
Summary
At the Annual Meeting held on May 21, 2025, Thermo Fisher Scientific Inc.'s shareholders elected the following nominees to the Board of Directors: Marc N. Casper, Nelson J. Chai, Ruby R. Chandy, C. Martin Harris, Tyler Jacks, Jennifer M. Johnson, R. Alexandra Keith, Karen S. Lynch, James C. Mullen, Debora L. Spar, and Scott M. Sperling. Dion J. Weisler was also elected. The non-binding advisory proposal on executive compensation was not approved. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm was ratified. The shareholder proposal to remove the one-year holding period requirement to call a special meeting was not approved.
Profitelligence Alerts
Get alerts for TMO
Be first to know when Thermo Fisher Scientific Inc. files with the SEC.
Filing Categories
Advertisement
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Official SEC Documents
Advertisement